260 related articles for article (PubMed ID: 15381707)
1. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.
Wang P; Nie J; Pei D
J Biol Chem; 2004 Dec; 279(49):51148-55. PubMed ID: 15381707
[TBL] [Abstract][Full Text] [Related]
2. Complete restoration of cell surface activity of transmembrane-truncated MT1-MMP by a glycosylphosphatidylinositol anchor. Implications for MT1-MMP-mediated prommp2 activation and collagenolysis in three-dimensions.
Nie J; Pei J; Blumenthal M; Pei D
J Biol Chem; 2007 Mar; 282(9):6438-43. PubMed ID: 17158888
[TBL] [Abstract][Full Text] [Related]
3. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
Tam EM; Wu YI; Butler GS; Stack MS; Overall CM
J Biol Chem; 2002 Oct; 277(41):39005-14. PubMed ID: 12145314
[TBL] [Abstract][Full Text] [Related]
4. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
5. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.
Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H
Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration.
Cao J; Kozarekar P; Pavlaki M; Chiarelli C; Bahou WF; Zucker S
J Biol Chem; 2004 Apr; 279(14):14129-39. PubMed ID: 14729674
[TBL] [Abstract][Full Text] [Related]
7. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
8. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
9. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
10. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.
Iida J; Wilhelmson KL; Price MA; Wilson CM; Pei D; Furcht LT; McCarthy JB
J Invest Dermatol; 2004 Jan; 122(1):167-76. PubMed ID: 14962105
[TBL] [Abstract][Full Text] [Related]
11. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H; Okada Y; Seiki M
Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
[TBL] [Abstract][Full Text] [Related]
12. MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.
Atkinson SJ; Roghi C; Murphy G
Biochem J; 2006 Aug; 398(1):15-22. PubMed ID: 16686598
[TBL] [Abstract][Full Text] [Related]
13. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
[TBL] [Abstract][Full Text] [Related]
14. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
d'Ortho MP; Will H; Atkinson S; Butler G; Messent A; Gavrilovic J; Smith B; Timpl R; Zardi L; Murphy G
Eur J Biochem; 1997 Dec; 250(3):751-7. PubMed ID: 9461298
[TBL] [Abstract][Full Text] [Related]
15. Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils.
Matsuda A; Itoh Y; Koshikawa N; Akizawa T; Yana I; Seiki M
J Biol Chem; 2003 Sep; 278(38):36350-7. PubMed ID: 12860995
[TBL] [Abstract][Full Text] [Related]
16. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.
Suenaga N; Mori H; Itoh Y; Seiki M
Oncogene; 2005 Jan; 24(5):859-68. PubMed ID: 15558018
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
18. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of catalytic and pexin-like domains in membrane-type matrix metalloproteinase (MMP)-mediated pro-MMP-2 activation and collagenolysis.
Jiang A; Pei D
J Biol Chem; 2003 Oct; 278(40):38765-71. PubMed ID: 12878590
[TBL] [Abstract][Full Text] [Related]
20. Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier.
Zhuge Y; Xu J
J Biol Chem; 2001 May; 276(19):16248-56. PubMed ID: 11340084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
